4.8 Review

Prospects for point-of-care pathogen diagnostics using surface-enhanced Raman scattering (SERS)

期刊

CHEMICAL SOCIETY REVIEWS
卷 45, 期 14, 页码 3865-3882

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c5cs00828j

关键词

-

资金

  1. U.S. Food and Drug Administration's Critical Paths Initiative
  2. National Cancer Institute's Innovative Molecular Analysis Technologies (IMAT) Program
  3. National Institute of Allergy and Infectious Diseases Partnerships in Biodefense Program
  4. Bill and Melinda Gates Foundation
  5. Dengue Branch of the Centers for Disease Control
  6. U.S. Army's Dugway Proving Ground

向作者/读者索取更多资源

Surface-enhanced Raman scattering (SERS) has enabled the detection of pathogens and disease markers at extremely low levels. This review examines the potential impact of SERS in addressing unmet needs in pathogen diagnostics both in a traditional clinical setting and in the point of care (POC) arena. It begins by describing the strengths and weaknesses of today's diagnostics technologies in order to set a contextual stage for an overview which highlights a few of the many recent developments using SERS in biodefense, human and animal health, and monitoring food and water safety. These sections are followed by discussions of the challenges for the translation of these developments to POC settings, including the performance attributes and metrics for quantification of analytical and clinical figures of merit (e.g., limit of detection and clinical accuracy), and the pathways for large-scale test validation and the build-out of instrumentation and tests kits for POC deployment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据